Searched for
WHOLE VIRION INACTIVATED CORONA VIRUS
Warren Buffett on why bubbles end badly – even when everyone knows they willWarren Buffett compared bubble investors to Cinderella at the ball: Everyone plans to leave just before midnight, but they are dancing in a...- Over 1,500 bat species carry thousands of deadly viruses but rarely get sick, and scientists are only just beginning to understand whyBats possess a unique, preactivated innate immune defense that stops viruses from fully replicating, even after cell entry. This remarkable...
- "India has scientific capability to emerge as global leader in health technologies": NITI Aayog's Gobardhan DasIndia's largest biomedical event, 'Medical Innovations Patent Mitra: Innovators-to-Industry Connect', successfully took place in New Delhi....
- The Boys Season 5 Episode 8 OTT release details: When will the series finale release in India? Check date, time, plotThe Boys Season 5 is heading toward its final episode, Blood and Bone, which releases on May 20, 2026, on Prime Video. The finale will cont...
- In the shadow of COVID, health officials fight panic over Hantavirus outbreakA hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...
- Media reports on expired Covid vaccines being used in India false, misleading: Health ministryOn October 25, 2021, in response to Bharat Biotech International Limited's letter, the Central Drugs Standard Control Organisation (CDSCO) ...
- Covaxin may provide better defence against Omicron: Top health expertK Srinath Reddy called for laboratory and clinical tests to understand how the Omicron variant, which has the highest spike protein mutatio...
- Mix of Covishield, Covaxin yields better results, finds ICMR StudyThe study titled ‘Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime...
- Monthly production capacity of Covishield, Covaxin planned to be increased: GovtFrom January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...
- CoronaVac vaccine: its results are patchy, but the world can't ignore its usefulnessThe latter, developed by the Sinovac Biotech company, is the latest COVID-19 vaccine to be authorised for emergency use by the World Health...
- 11 per cent of total Covid cases in country reported in persons aged below 20: GovtMeanwhile, MoS Health Bharati Pravin Pawar revealed that the CDSCO has granted permission to conduct clinical trials of COVID-19 vaccines i...
- Covaxin phase 3 full trial data to be made public in July: Bharat BiotechThe indigenous whole virion inactivated SARS-Cov-2 virus vaccine company has also said that Covaxin will even undergo the phase 4 trials to...
- Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-oldsThe Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization deliberated upon Hyderabad-based Bharat Biotech...
- Bharat Biotech gets nod for phase 2/3 clinical trials of Covaxin on 2 to 18-year-oldsOn Tuesday, the Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) deliberated upon Hyderabad-...
- Covaxin works on Brazil, South Africa strains, initial findings showA study in January had said the shot can protect against the UK variant. Dr Samiran Panda, head of the ICMR’s epidemiology and communicable...
- Russia approves its third COVID-19 vaccine: Prime Minister Mikhail MishustinRussia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a simi...
- No data generated with Covishield, Covaxin on 'European' strain of coronavirus, Rajya Sabha toldTo a question on whether the Covishield and Covaxin are able to provide protection from the new coronavirus variant that was traced in the ...
- India starts its vaccination drive today. For Covaxin, signed informed consent mustThose who get Covishield, the official said, no such follow-up will be done and beneficiaries will be required to inform only if they face ...
- DCGI approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situationThe subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.
- AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin"AIIMS, New Delhi is a site for COVAXIN Phase III clinical trial. This is a whole-virion inactivated vaccine co-sponsored by Indian Council...
Load More
